2025 · 2nd Quarter (Apr 1 - June 30)
Filed by ADVANCED MEDICAL TECHNOLOGY ASSN.
Open official filingSource-reported fields
Expense method: A
Literal source text
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act Issues related to Medicare coverage of FDA's breakthrough devices
Literal federal measure citations: H.R. 1691, S. 1000, H.R. 2377
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology Issues related to FDAs third party review program Issues related to the President's Emergency Program for AIDS Relief (PEPFAR)
Literal federal measure citations: H.R. 2369, HR 3723, HR 5662, S 2907, S 2672, HR 3795
Issues related to appropriations and user fee funding for the Food and Drug Administration Issues related to appropriations for AI reimbursement and focused ultrasound
Issues related to R&D Expense Amortization
Tariffs on medical devices United States-Mexico-Canada Agreement (USMCA) Global Trade and EU Tariffs Export Controls on Biotech lab equipment US Brazil ATEC Protocol Japan Reimbursement
Issues related to the reauthorization of the Small Business Innovation Research (SBIR) program.
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.
